ENOUGH: Funding, Investors & Team (Oct 2026)
ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). This gives integrated fermentation production of Food, Fuel and Feed.
ENOUGH has raised $49.9M across 2 funding rounds on record, the most recent a Series C announced in Feb 2024.
ENOUGH Company Profile and Key Stats
Latest funding round on record: Feb 2024.
ENOUGH Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
ENOUGH raised $49.9M in an undisclosed round announced in Jun 2021.
2.7 years later, a Series C was announced in Feb 2024 with no disclosed amount.
ENOUGH Founders and Leadership Team
No contact details are on record for this team yet.
ENOUGH Funding Compared to Other Biotechnology Startups
Funded Startups Like ENOUGH in Biotechnology and Glasgow
Companies Similar to ENOUGH
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
ENOUGH Funding FAQs
What does ENOUGH do?
ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). This gives integrated fermentation production of Food, Fuel and Feed.
How much funding has ENOUGH raised?
ENOUGH has raised $49.9M across 2 rounds on record.
When did ENOUGH last raise funding?
ENOUGH's most recent funding round on record was announced in Feb 2024. The amount was not disclosed.
Who founded ENOUGH?
FundedIQ lists Craig Johnston (Founder) at ENOUGH.
Who is the CEO of ENOUGH?
Jim Laird is listed as CEO at ENOUGH.
Where is ENOUGH headquartered?
ENOUGH is based in Glasgow, United Kingdom.
How many employees does ENOUGH have?
ENOUGH is in the 51-100 employee band.
About FundedIQ's ENOUGH Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ENOUGH is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.